{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:05:28Z","timestamp":1790888728008,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Pingtung Christian Hospital (Taiwan) through Luke International Malawi","award":["PS-IR-108001"],"award-info":[{"award-number":["PS-IR-108001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Bacterial infections are a significant cause of sickness and death in sub-Saharan Africa. This study aimed at establishing the prevalence, distribution and antimicrobial susceptibility pattern of major bacterial isolates from patients accessing medical care at a tertiary hospital in Malawi.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively reviewed bacteria culture and antimicrobial susceptibility records for 4617 patients from 2002 to 2014 at Mzuzu Central Hospital (MCH). No inclusion and exclusion criteria were followed. Data was analysed using excel (Microsoft office, USA) and GraphPad prism 7 software programs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The most prevalent isolates were\n                      <jats:italic>S. aureus<\/jats:italic>\n                      (34.7%,\n                      <jats:italic>n<\/jats:italic>\n                      = 783),\n                      <jats:italic>Klebsiella<\/jats:italic>\n                      species (17.4%,\n                      <jats:italic>n<\/jats:italic>\n                      = 393) and\n                      <jats:italic>Proteus<\/jats:italic>\n                      species (11.4%,\n                      <jats:italic>n<\/jats:italic>\n                      = 256). Most microorganisms were isolated from adults (88.3%,\n                      <jats:italic>n<\/jats:italic>\n                      = 3889) and pus was the main source (69.3%,\n                      <jats:italic>n<\/jats:italic>\n                      = 1224).\n                      <jats:italic>S. pneumoniae<\/jats:italic>\n                      was predominantly isolated from cerebrospinal fluid (60.3%,\n                      <jats:italic>n<\/jats:italic>\n                      = 44) largely collected from children (88.2%,\n                      <jats:italic>n<\/jats:italic>\n                      = 64). Overall, most bacteria exhibited high resistance to all regularly used antimicrobials excluding ciprofloxacin.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our report demonstrates an increase in bacterial infection burden in sites other than blood stream and subsequent increase in prevalence of antimicrobial resistance for all major isolates. Creating an epidemiological survey unit at MCH will be essential to help inform better treatment and management options for patients with bacterial infections.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-020-05725-w","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T12:03:50Z","timestamp":1610021030000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Prevalence, distribution and antimicrobial susceptibility pattern of bacterial isolates from a tertiary Hospital in Malawi"],"prefix":"10.1186","volume":"21","author":[{"given":"Pizga","family":"Kumwenda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel C.","family":"Adukwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebot S.","family":"Tabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor. C.","family":"Ujor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pocha S.","family":"Kamudumuli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maono","family":"Ngwira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph Tsung Shu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8301-6184","authenticated-orcid":false,"given":"Master R. O.","family":"Chisale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,7]]},"reference":[{"issue":"11","key":"5725_CR1","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/S1473-3099(18)30310-4","volume":"18","author":"C Troeger","year":"2018","unstructured":"Troeger C, et al. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990\u20132016: a systematic analysis for the global burden of disease study 2016. Lancet Infect Dis. 2018;18(11):1191\u2013210.","journal-title":"Lancet Infect Dis"},{"key":"5725_CR2","unstructured":"WHO. World health statistics 2016: monitoring health for the SDGs sustainable development goals. Geneva: World Health Organization; 2016."},{"issue":"2","key":"5725_CR3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ijantimicag.2004.02.015","volume":"24","author":"D Byarugaba","year":"2004","unstructured":"Byarugaba D. Antimicrobial resistance in developing countries and responsible risk factors. Int J Antimicrob Agents. 2004;24(2):105\u201310.","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"5725_CR4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/nyas.12380","volume":"1323","author":"S Kariuki","year":"2014","unstructured":"Kariuki S, Dougan G. Antibacterial resistance in sub-Saharan Africa: an underestimated emergency. Ann N Y Acad Sci. 2014;1323(1):43.","journal-title":"Ann N Y Acad Sci"},{"issue":"10","key":"5725_CR5","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/S1473-3099(17)30394-8","volume":"17","author":"P Musicha","year":"2017","unstructured":"Musicha P, et al. Trends in antimicrobial resistance in bloodstream infection isolates at a large urban hospital in Malawi (1998\u20132016): a surveillance study. Lancet Infect Dis. 2017;17(10):1042\u201352.","journal-title":"Lancet Infect Dis"},{"key":"5725_CR6","unstructured":"Mbanga J, Dube S, Munyanduki H. Prevalence and drug resistance in bacteria of the urinary tract infections in Bulawayo province, Zimbabwe. East Afr J Public Health. 2010;7(3):229\u201332."},{"issue":"10","key":"5725_CR7","doi-asserted-by":"publisher","first-page":"e0223598","DOI":"10.1371\/journal.pone.0223598","volume":"14","author":"N Attram","year":"2019","unstructured":"Attram N, et al. Antimicrobial resistance (AMR) and molecular characterization of Neisseria gonorrhoeae in Ghana, 2012-2015. PLoS One. 2019;14(10):e0223598.","journal-title":"PLoS One"},{"issue":"2","key":"5725_CR8","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1016\/S1473-3099(17)30467-X","volume":"18","author":"PC Williams","year":"2018","unstructured":"Williams PC, Isaacs D, Berkley JA. Antimicrobial resistance among children in sub-Saharan Africa. Lancet Infect Dis. 2018;18(2):e33\u201344.","journal-title":"Lancet Infect Dis"},{"key":"5725_CR9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3389\/fpubh.2014.00145","volume":"2","author":"CA Michael","year":"2014","unstructured":"Michael CA, Dominey-Howes D, Labbate M. The antimicrobial resistance crisis: causes, consequences, and management. Front Public Health. 2014;2:145.","journal-title":"Front Public Health"},{"key":"5725_CR10","doi-asserted-by":"crossref","unstructured":"Cheesbrough M. District laboratory practice in tropical countries. Tropical Health Technology, Norfolk: Cambridge university press; 2006.","DOI":"10.1017\/CBO9780511543470"},{"key":"5725_CR11","first-page":"26","volume":"2","author":"Z Daoud","year":"2015","unstructured":"Daoud Z, et al. Escherichia coli isolated from urinary tract infections of Lebanese patients between 2005 and 2012: epidemiology and profiles of resistance. Front Med. 2015;2:26.","journal-title":"Front Med"},{"key":"5725_CR12","volume-title":"Twenty-Second Informational Supplement ed","author":"CLSI","year":"2012","unstructured":"CLSI. Performance standards for antimicrobial susceptibility testing. In: Twenty-Second Informational Supplement ed, vol. 32. Wayne, PA: Clinical and Laboratory Standard Institute, CLSI document M100-S22; 2012."},{"key":"5725_CR13","doi-asserted-by":"crossref","unstructured":"Feasey NA, Houston A, Mukaka M, Komrower D, Mwalukomo T, Tenthani L, et al. A reduction in adult blood stream infection and case fatality at a large African hospital following antiretroviral therapy roll-out. PLoS One. 2014;9(3):e92226.","DOI":"10.1371\/journal.pone.0092226"},{"issue":"11","key":"5725_CR14","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.3201\/eid2011.141175","volume":"20","author":"NA Feasey","year":"2014","unstructured":"Feasey NA, et al. Drug resistance in Salmonella enterica ser. Typhimurium bloodstream infection, Malawi. Emerg Infect Dis. 2014;20(11):1957.","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"5725_CR15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/cid\/ciy834","volume":"69","author":"P-Y Iroh Tam","year":"2019","unstructured":"Iroh Tam P-Y, et al. Emerging resistance to empiric antimicrobial regimens for pediatric bloodstream infections in Malawi (1998\u20132017). Clin Infect Dis. 2019;69(1):61\u20138.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"5725_CR16","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1086\/376507","volume":"188","author":"LK Archibald","year":"2003","unstructured":"Archibald LK, et al. Epidemiology of bloodstream infections in a bacille Calmette-Guerin-vaccinated pediatric population in Malawi. J Infect Dis. 2003;188(2):202\u20138.","journal-title":"J Infect Dis"},{"issue":"8","key":"5725_CR17","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1111\/j.1365-3156.2004.01288.x","volume":"9","author":"RP Peters","year":"2004","unstructured":"Peters RP, et al. A prospective study of bloodstream infections as cause of fever in Malawi: clinical predictors and implications for management. Tropical Med Int Health. 2004;9(8):928\u201334.","journal-title":"Tropical Med Int Health"},{"issue":"2","key":"5725_CR18","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/01.inf.0000109258.82988.40","volume":"23","author":"EB NORTON","year":"2004","unstructured":"NORTON EB, et al. Clinical predictors of bloodstream infections and mortality in hospitalized Malawian children. Pediatr Infect Dis J. 2004;23(2):145\u201351.","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"5725_CR19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1471-2334-12-67","volume":"12","author":"MH Makoka","year":"2012","unstructured":"Makoka MH, et al. Bacterial infections in Lilongwe, Malawi: aetiology and antibiotic resistance. BMC Infect Dis. 2012;12(1):67.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"5725_CR20","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0305-4179(02)00273-5","volume":"29","author":"O Komolafe","year":"2003","unstructured":"Komolafe O, et al. Bacteriology of burns at the queen elizabeth central hospital, Blantyre, Malawi. Burns. 2003;29(3):235\u20138.","journal-title":"Burns"},{"key":"5725_CR21","doi-asserted-by":"crossref","unstructured":"Maina D, Omuse G, Gunturu Revathi RDA. Spectrum of microbial diseases and resistance patterns at a private teaching hospital in Kenya: implications for clinical practice. PLoS One. 2016;11(1):e0147659.","DOI":"10.1371\/journal.pone.0147659"},{"issue":"3","key":"5725_CR22","first-page":"261","volume":"37","author":"A Okesola","year":"2008","unstructured":"Okesola A, Kehinde A. Bacteriology of non-surgical wound infections in Ibadan, Nigeria. Afr J Med Med Sci. 2008;37(3):261\u20134.","journal-title":"Afr J Med Med Sci"},{"key":"5725_CR23","unstructured":"Biadglegne F, Abera B, Alem A, Anagaw B. Bacterial isolates from wound infection and their antimicrobial susceptibility pattern in Felege Hiwot referral Hospital North West Ethiopia. Ethiop J Health Sci. 2009;19(3):1029\u2013857."},{"issue":"1","key":"5725_CR24","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1186\/s12879-016-2082-1","volume":"16","author":"N Moremi","year":"2016","unstructured":"Moremi N, Claus H, Mshana SE. Antimicrobial resistance pattern: a report of microbiological cultures at a tertiary hospital in Tanzania. BMC Infect Dis. 2016;16(1):756.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"5725_CR25","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1128\/CMR.00134-14","volume":"28","author":"SY Tong","year":"2015","unstructured":"Tong SY, et al. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015;28(3):603\u201361.","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"5725_CR26","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0732-8893(02)00543-6","volume":"45","author":"RP Rennie","year":"2003","unstructured":"Rennie RP, et al. Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections: report from the SENTRY antimicrobial surveillance program (United States and Canada, 2000). Diagn Microbiol Infect Dis. 2003;45(4):287\u201393.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"5725_CR27","unstructured":"Mordi R, Momoh M. Incidence of Proteus species in wound infections and their sensitivity pattern in the University of Benin Teaching Hospital. Afr J Biotechnol. 2009;8(5):1684\u20135315."},{"issue":"9","key":"5725_CR28","first-page":"DC14","volume":"9","author":"N Perween","year":"2015","unstructured":"Perween N, Prakash SK, Siddiqui O. Multi drug resistant Klebsiella isolates in burn patients: a comparative study. J Clin Diagn Res. 2015;9(9):DC14.","journal-title":"J Clin Diagn Res"},{"key":"5725_CR29","doi-asserted-by":"crossref","unstructured":"Oordt-Speets AM, Bolijn R, van Hoorn RC, Bhavsar A, Kyaw MH. Global etiology of bacterial meningitis: A systematic review and meta-analysis. PloS one. 2018;13(6):e0198772.","DOI":"10.1371\/journal.pone.0198772"},{"issue":"1","key":"5725_CR30","doi-asserted-by":"publisher","first-page":"152","DOI":"10.4269\/ajtmh.2010.09-0578","volume":"83","author":"I Mandomando","year":"2010","unstructured":"Mandomando I, et al. Antimicrobial drug resistance trends of bacteremia isolates in a rural hospital in southern Mozambique. Am J Trop Med Hyg. 2010;83(1):152\u20137.","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"5725_CR31","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3390\/antibiotics8020052","volume":"8","author":"M Gajd\u00e1cs","year":"2019","unstructured":"Gajd\u00e1cs M. The continuing threat of methicillin-resistant Staphylococcus aureus. Antibiotics. 2019;8(2):52.","journal-title":"Antibiotics"},{"issue":"1","key":"5725_CR32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1086\/313910","volume":"31","author":"SB Gordon","year":"2000","unstructured":"Gordon SB, et al. Bacterial meningitis in Malawian adults: pneumococcal disease is common, severe, and seasonal. Clin Infect Dis. 2000;31(1):53\u20137.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"5725_CR33","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1097\/01.inf.0000260253.22994.61","volume":"26","author":"ED Carrol","year":"2007","unstructured":"Carrol ED, et al. High pneumococcal DNA loads are associated with mortality in Malawian children with invasive pneumococcal disease. Pediatr Infect Dis J. 2007;26(5):416.","journal-title":"Pediatr Infect Dis J"},{"issue":"9328","key":"5725_CR34","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0140-6736(02)09458-8","volume":"360","author":"E Molyneux","year":"2002","unstructured":"Molyneux E, et al. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet. 2002;360(9328):211\u20138.","journal-title":"Lancet"},{"issue":"10","key":"5725_CR35","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1097\/00002030-200207050-00013","volume":"16","author":"SB Gordon","year":"2002","unstructured":"Gordon SB, et al. Pneumococcal disease in HIV-infected Malawian adults: acute mortality and long-term survival. AIDS (London, England). 2002;16(10):1409.","journal-title":"AIDS (London, England)"},{"issue":"1","key":"5725_CR36","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13756-018-0388-z","volume":"7","author":"W-P Tseng","year":"2018","unstructured":"Tseng W-P, et al. Risk for subsequent infection and mortality after hospitalization among patients with multidrug-resistant gram-negative bacteria colonization or infection. Antimicrob Resist Infect Control. 2018;7(1):93.","journal-title":"Antimicrob Resist Infect Control"},{"key":"5725_CR37","volume-title":"Malawi Standard Treatment Guidelines","author":"Health, M.M.o","year":"2015","unstructured":"Health, M.M.o, Malawi Standard Treatment Guidelines. 2015."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05725-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-020-05725-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05725-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T14:04:51Z","timestamp":1610287491000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05725-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,7]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["5725"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05725-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-36411\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-36411\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-36411\/v3","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,7]]},"assertion":[{"value":"15 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval for the study was obtained from National Health Science Research Committee (NHSRC), (approval number NHSRC # 1206). The permission to access the raw data from was granted by the National Health Science Research Committee (NHSRC) and Mzuzu Central Hospital research ethics committee. No consent was obtained from individual participants since this was a retrospective study. However, the participant\u2019s data was anonymized through use of serial numbers.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34"}}